Marietta, Pennsylvania — According to state and local development sources, GSK plans to invest $800,000,000.00 to build out new space in Marietta. The company plans to occupy the new space at 325 North Bridge Street in Marietta, on or about December 1, 2026. According to the company website GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

To learn more about GSK, visit http://www.gsk.com/

Company Contact:
Emma Walmsley, Chief Executive Officer
https://www.linkedin.com/in/emmawalmsleygsk/
215-751-4000

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.